Arcturus Therapeutics Holdings Inc. Common Stock

ARCTNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
15.84 USD
↗ 0.55 (3.60%)AT CLOSE (11:59 AM EDT)
15.65
↘ 0.19 (1.20%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
15.65
↘ 0.19 (1.20%)
🔴Market: CLOSED

Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) trades at $15.85 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place ARCT at a fair price relative to peers.

Technical & fundamental data as of Sep 15, 2026.

Open?$15.34
High?$15.99
Low?$14.76
Prev. Close?$15.29
Volume?556.2K
Avg. Volume?1.3M
VWAP?$15.57
Rel. Volume?0.44x
Bid / Ask
Bid?$15.30 × 800
Ask?$15.98 × 400
Spread?$0.68
Midpoint?$15.64
Valuation & Ratios
Market Cap?450.2M
Shares Out?28.4M
Float?22.8M
Float %?80.1%
P/E Ratio?N/A
P/B Ratio?2.62
EPS?-$3.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsBiotech - Drug Development›Infectious Disease & Vaccines
Employees
111
Market Cap
434.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.arcturusrx.com
Listed
2013-05-22
Address
10285 SCIENCE CENTER DRIVE
SAN DIEGO, CA
Phone: (858) 900-2660
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
13
Momentum?
10
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?1.12Distress
Confidence?72%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?26.77%Squeeze Risk
Short Interest?6.1M
Days to Cover?3.1
Free Float22.8M
Avg Daily Volume2.0M
Settlement Date2026-08-31
Financial Health
Current Ratio?5.88Strong
Quick Ratio?5.88Strong
Cash Ratio?5.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
62
2.62CHEAP▾
P/S?
Peers
100
S&P
3
15.33HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.6CHEAP▾
EV/Sales?
Peers
100
S&P
14
8.81HIGH▾
Returns & Efficiency
ROE?
S&P
3
-54.3%WEAK▾
ROA?
S&P
3
-41.6%WEAK▾
Cash Flow & Enterprise
FCF?$-72822000
Enterprise Value?$258.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist